Drug Information

Drug General Information
Drug ID
D06GUA
Former ID
DIB012220
Drug Name
GSK2269557
Indication Chronic obstructive pulmonary disease; Asthma [ICD9: 490-492, 493, 494-496; ICD10:J40-J44, J47, J45] Phase 2 [525290]
Company
Glaxosmithkline
Structure
Download
2D MOL

3D MOL
Target and Pathway
Target(s) Stress kinase p38 Target Info Inhibitor [531958]
References
Ref 525290ClinicalTrials.gov (NCT02522299) A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute Exacerbation.
Ref 531958Evaluation of WO2012032067 and WO2012055846: two selective PI3Kdelta inhibitors, which is GSK-2269557. Expert Opin Ther Pat. 2012 Aug;22(8):965-70.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.